Injection of recombinant mouse CCL20 into CRC promoted tumor development with a marked recruitment of Treg-cells in wild-type mice, and stimulated tumor growth by directly activating CMT93 cells in CCR6−/− mice. This evidence concerns the gene CCL20 and colorectal carcinoma.